Phase II study of oral vinorelbine in combination with capecitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes
Phase II study of oral vinorelbine in combination with capecitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes
Phase II study of oral vinorelbine in combination with capecitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
75
Years old
Gender
Female
Therapeutic area :
Oncology
Disease :
Breast cancer
Study medication :
Vinorelbine (Navelbine® Oral)
Phase :
Phase II
Start Date :
08 September 2004
End date :
19 December 2007
Study ID :
PM0259 CA 220 B0
EudraCT/CTIS number :
2004-000665-35
Send by email